Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | Y234C |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TP53 Y234C lies within the DNA-binding domain of the Tp53 protein (PMID: 22713868). Y234C results in decreased Tp53 transactivation and interferes with wild-type Tp53 function in cell culture, and correlates with protein aggregates in human tumor samples (PMID: 21056685, PMID: 16861262). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon7 TP53 Y234C TP53 mutant TP53 inact mut TP53 Y234C |
Transcript | NM_000546.6 |
gDNA | chr17:g.7674262T>C |
cDNA | c.701A>G |
Protein | p.Y234C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126113.2 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7674262T>C | c.701A>G | p.Y234C | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
TP53 Y234C | ovarian carcinoma | sensitive | ReACp53 | Preclinical | Actionable | In a preclinical study, ReACp53 induced cell death in human primary ovarian carcinoma cells harboring TP53 Y234C in culture (PMID: 26748848). | 26748848 |
TP53 Y234C | lung non-small cell carcinoma | decreased response | Seliciclib | Preclinical - Cell culture | Actionable | In a preclinical study, non-small cell lung carcinoma cells overexpressing TP53 Y234C demonstrated reduced sensitivity to Roscovotine (seliciclib) induced apoptosis in culture (PMID: 22862161). | 22862161 |